Eli Lilly and Company's Tirzepatide GLP-1 Agonist For Weight Loss Reverses Fatty Liver Disease in a Clinically Meaningful Way

All doses of Eli Lilly and Company's GLP-1 agonist, Tirzepatide, managed to reverse MASH without worsening fibrosis.

Related Keywords

Eli Lilly ,Walter Bloomberg Deitaone ,Facebook ,Twitter ,Company Mounjaro ,Novo Nordisk ,Associated Steatohepatitis ,Nonalcoholic Ateatohepatitis ,Glucose Dependent Insulinotropic Polypeptide ,Wall Street ,Walter Bloomberg ,